GSA Capital Partners’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Buy
555,036
+459,520
+481% +$1.08M 0.07% 444
2025
Q4
$259K Buy
+95,516
New +$314K 0.02% 1254
2025
Q3
Sell
-77,808
Closed -$387K 1803
2025
Q2
$387K Buy
+77,808
New +$338K 0.03% 1100
2025
Q1
Sell
-448,374
Closed -$2.08M 1803
2024
Q4
$2.08M Buy
448,374
+282,799
+171% +$1.55M 0.15% 80
2024
Q3
$1.15M Sell
165,575
-2,557
-2% -$20.1K 0.09% 378
2024
Q2
$1.31M Sell
168,132
-62,565
-27% -$463K 0.09% 340
2024
Q1
$1.64M Buy
+230,697
New +$1.53M 0.13% 191
2023
Q4
Sell
-116,658
Closed -$657K 1650
2023
Q3
$657K Buy
116,658
+65,099
+126% +$434K 0.06% 630
2023
Q2
$285K Sell
51,559
-63,170
-55% -$340K 0.03% 1079
2023
Q1
$717K Sell
114,729
-50,294
-30% -$280K 0.07% 499
2022
Q4
$769K Buy
165,023
+51,460
+45% +$254K 0.1% 345
2022
Q3
$530K Buy
113,563
+80,808
+247% +$509K 0.07% 525
2022
Q2
$194K Buy
+32,755
New +$365K 0.03% 1078
2021
Q4
Sell
-5,229
Closed -$214K 1542
2021
Q3
$214K Buy
+5,229
New +$190K 0.02% 1206
2020
Q4
Sell
-15,000
Closed -$834K 1340
2020
Q3
$834K Buy
+15,000
New +$794K 0.14% 152

Other funds holding GDRX

GSA Capital Partners's GDRX Position: Q1 2026 in Review

GSA Capital Partners increased its GoodRx Holdings (GDRX) stake by 481% in Q1 2026, buying an estimated $1.08M and bringing the position to 555,036 shares worth $1.09M. The position accounts for 0.07% of the portfolio, ranked #444.

GSA Capital Partners first reported a position in GDRX in Q3 2020 and has held it in 15 quarters since. The position peaked at $2.08M in Q4 2024. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • GSA Capital Partners held 555,036 shares of GoodRx Holdings worth $1.09M as of Q1 2026.
  • GSA Capital Partners bought 459,520 GoodRx Holdings shares in Q1 2026, an estimated $1.08M.
  • GoodRx Holdings made up 0.07% of GSA Capital Partners's portfolio in Q1 2026, its #444 holding.
  • GSA Capital Partners first reported a position in GoodRx Holdings in Q3 2020 and has held it in 15 quarters since.
  • GSA Capital Partners's GoodRx Holdings position peaked at $2.08M in Q4 2024.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.